Proposal for a modified grading system based on mitotic index and Bcl2 provides objective determination of clinical outcome for patients with breast cancer.
第一作者:
Tarek M A,Abdel-Fatah
第一单位:
Division of Pathology, School of Molecular Medical Sciences and Nottingham University Hospitals Trust, University of Nottingham, Nottingham, UK.
作者:
主题词
老年人(Aged);乳腺肿瘤(Breast Neoplasms);化学疗法, 辅助(Chemotherapy, Adjuvant);女(雌)性(Female);人类(Humans);淋巴转移(Lymphatic Metastasis);中年人(Middle Aged);有丝分裂指数(Mitotic Index);肿瘤分期(Neoplasm Staging);预后(Prognosis);原癌基因蛋白质c-bcl-2(Proto-Oncogene Proteins c-bcl-2);存活率分析(Survival Analysis);治疗结果(Treatment Outcome)
DOI
10.1002/path.2775
PMID
20922713
发布时间
2015-11-19
- 浏览121

The Journal of pathology
388-99页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文